CSL has FDA approval for its new drug to prevent hereditary angioedema (HAE) attacks, Andembry, offering a new, first-in-class option for patients with the rare genetic disorder. Factor XIIa inhibitor ...
CSL has said that with flu jab rates in the US down between 12% and 14% this year, it has decided to delay the planned spinout of its Seqirus vaccines business and cut its profit forecast for the ...
Thursday, February 12, 2026: The Club says it’ll trim its position in this power giant following a strong rally Got a confidential news tip? We want to hear from you. Sign up for free newsletters and ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
About DuPont de Nemours Inc. DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results